Investor Relations

Investor Overview

KemPharm uses its LATTMplatform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.

Stock Quote

More >>
More >>

Upcoming Events

Copyright Nasdaq. Minimum 15 minutes delayed.